The journey from concept to commercialization for cell therapy candidates is fraught with complex challenges, including escalating costs in process development, difficulties in scaling academic research to clinical applications, and navigating a competitive regulatory landscape.
In this webinar, cell therapy leaders from Stanford School of Medicine, BioLabs, and Thermo Fisher Scientific will delve into how they have addressed key development hurdles. With a focus on delivering practical, high-impact outcomes, the speakers will share their experiences in overcoming cost and scalability barriers, and leveraging innovative technologies to optimize cell therapy process workflows and enhance efficiency.